Biorestorative Therapies, Inc. (BRTX) vs Clearside Biomedical, Inc. (CLSDQ)
- Biorestorative Therapies, Inc. BRTX 1.52 +4.11%
- Clearside Biomedical, Inc. CLSDQ 0.25 0.00%
Biorestorative Therapies, Inc. and Clearside Biomedical, Inc. are both Biotechnology companies. Biorestorative Therapies, Inc. and Clearside Biomedical, Inc. are of similar size ($2.2M and $2.0M). Biorestorative Therapies, Inc. grew revenue faster over the last twelve months: −8.47% against −56.8%. Clearside Biomedical, Inc. has the higher net margin (−780.9% vs −3,089.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Clearside Biomedical, Inc. leads on 9 and Biorestorative Therapies, Inc. on 7.
Valuation
Profitability
| Metric | BRTX | CLSDQ | Biotechnology median |
|---|---|---|---|
| Gross margin | 92.09% | 92.55% | 65.16% |
| Operating margin | (3,974.66%) | (689.76%) | 0.00% |
| Net margin | (3,089.30%) | (780.93%) | 0.00% |
| Free cash flow margin | (3,302.04%) | (653.23%) | 0.00% |
| Return on equity | (241.50%) | 58.59% | (56.36%) |
| Return on assets | (147.75%) | (127.43%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack